pharmaceutical industry
- H
Beyond Generics: How Policy and Investment are Positioning India as a Drug Discovery Hub
India Pharma Poised to Lead Global Biologics Boom as Government Unveils Mega Initiatives New Delhi, Apr 13 India is strategically positioned to assume a leading role in the rapidly evolving global pharmaceutical landscape. With the industry shifting focus towards biologics, biosimilars, and... - H
India's Pharma Industry Sees Continued Growth Amid Global Challenges
New Delhi, April 5: India's pharmaceutical exports reached over $28 billion by February of the current financial year, registering a growth of more than 5 per cent compared to the same period last year, a senior government official has said.Speaking at the inaugural session of ‘Chintan Shivir... - H
Marksans Pharma Expands Generic Portfolio with USFDA Approval
New Delhi, April 1 Marksans Pharma Ltd announced on Wednesday that it has received final approval from the US health regulator for its generic version of Benzonatate capsules, indicated for the treatment of persistent cough, bronchitis, pneumonia, or other lung infections.The approval from the...- Himanshu
- Thread
- abbreviated new drug application (anda) benzonatate bioequivalence bronchitis treatment cough treatment generic drug approval lung infections marksans pharma non-narcotic antitussive pfizer inc. pharmaceutical industry pneumonia treatment tessalon capsules therapeutic equivalence us food and drug administration (usfda)
- Replies: 0
- Forum: Business
- H
MPCB Enforcement Lapses: CAG Report Highlights Industry Non-Compliance
Mumbai, March 25 The Comptroller and Auditor General of India (CAG) has raised serious concerns about the functioning of the Maharashtra Pollution Control Board (MPCB) between 2017 and 2022, stating that many industries were found to be operating without the necessary permits and discharging...- Himanshu
- Thread
- continuous emission monitoring systems effluent treatment plants environmental compliance audit industrial permits inspection visits maharashtra pollution control board mpcb paper industry pharmaceutical industry physical verification regulatory oversight sugar industry wastewater discharge water pollution
- Replies: 0
- Forum: Business
- H
Lupin's Generic Drug for Daytime Sleepiness Receives USFDA Review
Lupin Receives Tentative USFDA Approval for Generic Pitolisant Tablets New Delhi, March 25 – Lupin Ltd announced on Wednesday that it has received tentative approval from the US health regulator for its generic version of Pitolisant tablets, indicated for the treatment of excessive daytime...- Himanshu
- Thread
- abbreviated new drug application drug development drug manufacturing excessive daytime sleepiness generic pharmaceuticals healthcare india lupin ltd nagpur pharmaceutical approval pharmaceutical industry pitolisant regulatory filings tablet us food and drug administration (usfda)
- Replies: 0
- Forum: Business
- H
Potential Impact on Affordable Vaccines: Maharashtra Leader Questions Haffkine Transfer
Maharashtra Congress Opposes Move to Transfer Haffkine’s DPT Vaccine Strain to Private Firm Concerns Raised Over Public Health and Vaccine Affordability Mumbai, March 24: Maharashtra Congress Legislature Party leader Vijay Wadettiwar on Tuesday opposed the reported move to transfer a rare and...- Himanshu
- Thread
- bioethics biological resources dpt vaccine dr waldemar mordecai haffkine expression of interest haffkine institute india maharashtra congress medical research pharmaceutical industry public health reliance life sciences state assembly vaccine production vaccine strain
- Replies: 0
- Forum: Business
- H
Pharmaceuticals: India's Expanding Role in Global Healthcare
India’s Pharmaceutical Industry Strengthens Global Position, Eyes $130 Billion Market by 2030 Sector Ranks Third Globally by Volume with Expanding Manufacturing Base New Delhi, March 21: India’s pharmaceutical industry continues to solidify its position as a globally integrated and...- Himanshu
- Thread
- active pharmaceutical ingredients (apis) domestic production economic survey generic medicines healthcare supply networks india market size pharmaceutical exports pharmaceutical industry pharmaceutical manufacturing pharmaceutical market trade agreements unicef usfda vaccine supply world health organization (who)
- Replies: 0
- Forum: Business
- K
Cipla Recalls Anti-Cancer Drug Nilotinib Due to Manufacturing Issue
Cipla’s US Arm Recalls Over 400 Cartons of Generic Anti Cancer Drug Nilotinib: USFDA Manufacturing Issue Triggers Recall of Nilotinib Capsules in Two Strengths New Delhi, March 8: Cipla’s US-based subsidiary has recalled more than 400 cartons of a generic anti cancer medication from the United...- Karthik
- Thread
- anti-cancer medicine cancer treatment cipla generic medicine generics market india manufacturing issue nilotinib pharmaceutical industry pharmaceutical manufacturing pharmaceutical recall sun pharmaceutical industries united states us food and drug administration (usfda) warren, new jersey
- Replies: 0
- Forum: Business
- K
Shaily Engineering Plastics Ltd. Secures ₹423 Crore Pharma Contract, Plans Abu Dhabi Expansion
Shares of Shaily Engineering Plastics Ltd. are set to remain in focus on Thursday, February 26, after the company announced a significant manufacturing and commercial supply agreement valued at ₹423 crore.The contract, signed with a major domestic pharmaceutical company, involves the supply of...- Karthik
- Thread
- abu dhabi capacity expansion contract supply financial results investment plans joe kam manufacturing contracts manufacturing facilities medical devices medical devices manufacturing pen injectors pharmaceutical industry shaily engineering plastics ltd. stock performance
- Replies: 0
- Forum: Stocks
- K
Lupin Secures USFDA Approval for Generic Brivaracetam Oral Solution, Launches in US Market
Lupin Receives USFDA Nod for Seizure Treatment Drug Mumbai based pharmaceutical major Lupin Ltd on Wednesday announced that it has received approval from the U.S. Food and Drug Administration to market a generic medication used in the treatment of seizures in the United States.The approval... - K
Alembic Pharmaceuticals Secures USFDA Approval for Generic Efinaconazole Topical Solution
New Delhi, February 24: Alembic Pharmaceuticals on Tuesday announced that it has received final approval from the US Food and Drug Administration to market its generic version of Efinaconazole Topical Solution 10 percent in the United States.The approval marks a significant regulatory...- Karthik
- Thread
- alembic pharmaceuticals anda antifungal medication bausch health americas, inc. bse efinaconazole topical solution generic medication jublia topical solution market size onychomycosis pharmaceutical industry topical solution trichophyton mentagrophytes trichophyton rubrum us food & drug administration
- Replies: 0
- Forum: Business
- K
CDSCO Audits Over 90% of Cough Syrup Manufacturers, Aims to Eliminate Quality Issues by Next Season
1,250 Manufacturing Sites Inspected Under Risk Based Framework Mumbai, February 23: The Central Drugs Standard Control Organisation has completed audits of more than 90 per cent of cough syrup manufacturers across the country, as part of an intensified quality compliance drive. A senior official...- Karthik
- Thread
- audit capa (corrective and preventive action) central drugs standard control organisation cough syrup drugs controller general of india good manufacturing practices india mumbai pharmaceutical industry pharmaceutical manufacturing pharmaceutical quality quality control regulatory compliance risk-based inspection
- Replies: 0
- Forum: Business
- K
J P Nadda Urges Pharma Industry to Anchor Global Supply Chains with Quality and Innovation
India Calls for Trust, Reliability and Innovation in Redesigned Global Pharma Supply Chains Mumbai, February 23: Union Minister J P Nadda on Monday called upon India’s domestic pharmaceutical industry to take a leadership role in the evolving global supply chain by focusing not only on scale but...- Karthik
- Thread
- artificial intelligence biopharmaceutical manufacturing clinical trials disease detection global supply chain healthcare india innovation pharmaceutical industry pharmaceutical quality predictive diagnostics quality systems regulatory affairs research and development supply chain resilience
- Replies: 0
- Forum: Business
- K
Alkem Laboratories Receives USFDA Form 483 with Six Observations After Chakan Facility Inspection
USFDA Concludes Pre Approval Inspection at Enzene Biosciences Unit New Delhi, February 16: Alkem Laboratories on Monday said the United States health regulator has issued a Form 483 with six observations following an inspection of the manufacturing facility of its wholly owned subsidiary Enzene...- Karthik
- Thread
- alkem laboratories bse chakan data integrity drug firm enzene biosciences fd&c act form 483 india manufacturing unit pharmaceutical industry pharmaceutical manufacturing quality systems regulatory inspection us food and drug administration (usfda)
- Replies: 0
- Forum: Order & deals